Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda constant 4 (pseudogene) (IGLC4)
- Target
- IGLC4
- Molecular classification
- Other, Immunoglobulin light chain pseudogene
01
Overview
IGLC4 (immunoglobulin lambda constant 4) is classified as a pseudogene in the human genome, located within the immunoglobulin lambda locus on chromosome 22[2][3][4]. It is not expressed as a protein and thus does not participate in the biological activities typically associated with immunoglobulin light chain genes, such as antigen binding or immune response[2][4]. Functionally significant immunoglobulin lambda constant genes include IGLC1, IGLC2, IGLC3, and IGLC7, while IGLC4, along with IGLC5 and IGLC6, are considered non-functional pseudogenes in humans[2][4]. IGLC4 cannot be considered a therapeutic target or biological receptor, and it plays no direct role in disease, drug interaction, or patient selection. Its presence reflects the evolutionary history of the immunoglobulin gene family, which contains both functional genes and nonfunctional pseudogenes[2][4].
- Other names
- IGLC4IGLCimmunoglobulin lambda constant region 4 (pseudogene)
Beyond the preview
Go deeper on Immunoglobulin lambda constant 4 (pseudogene) (IGLC4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin lambda constant 4 (pseudogene) (IGLC4).